MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868955. A total of 7 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,896,828 | -70.3% | 115,700 | -53.0% | 0.00% | -66.7% |
| Q2 2023 | $56,872,200 | -0.8% | 246,200 | +4.1% | 0.01% | -14.3% |
| Q1 2023 | $57,319,000 | +628811.6% | 236,600 | +653.5% | 0.01% | +600.0% |
| Q4 2022 | $9,114 | -99.8% | 31,400 | -64.4% | 0.00% | 0.0% |
| Q3 2022 | $5,726,000 | – | 88,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 129,400 | $18,897,576 | 0.06% |
| JANE STREET GROUP, LLC | 194,300 | $28,375,572 | 0.01% |
| SIMPLEX TRADING, LLC | 15,200 | $2,219 | 0.00% |
| JPMORGAN CHASE & CO | 115,700 | $16,896,828 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |